| Dr Anupam Boparai, MD | |
|
1301 3rd St Ste 200, Wichita Falls, TX 76301-2245 | |
| (940) 767-5145 | |
| Not Available |
| Full Name | Dr Anupam Boparai |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1301 3rd St Ste 200, Wichita Falls, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225390420 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | BP10042842 (Texas) | Primary |
| Entity Name | Emergency Staffing Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477590974 PECOS PAC ID: 9830001650 Enrollment ID: O20050207000313 |
News Archive
NovaBay Pharmaceuticals, Inc. today announced that its lead product candidate was safe and efficacious against the highly contagious skin infection impetigo in a Phase 2a proof-of-concept clinical trial. This dose-ranging study showed that the drug cleared impetigo infections, including those in the trial caused by a drug-resistant strain of bacteria called methicillin-resistant Staphylococcus aureus or MRSA. Impetigo afflicts approximately 1 million people, primarily infants and children, in the United States annually.
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
In a small-scale study of women with previously diagnosed mood disorders, Johns Hopkins researchers report that lower levels of the hormone allopregnanolone in the second trimester of pregnancy were associated with an increased chance of developing postpartum depression in women already known to be at risk for the disorder.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported results through month 36 of the completed FAME™ Study.
With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?
› Verified 2 days ago
| Entity Name | Ess Hospitalist Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881967305 PECOS PAC ID: 6103085295 Enrollment ID: O20130603000588 |
News Archive
NovaBay Pharmaceuticals, Inc. today announced that its lead product candidate was safe and efficacious against the highly contagious skin infection impetigo in a Phase 2a proof-of-concept clinical trial. This dose-ranging study showed that the drug cleared impetigo infections, including those in the trial caused by a drug-resistant strain of bacteria called methicillin-resistant Staphylococcus aureus or MRSA. Impetigo afflicts approximately 1 million people, primarily infants and children, in the United States annually.
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
In a small-scale study of women with previously diagnosed mood disorders, Johns Hopkins researchers report that lower levels of the hormone allopregnanolone in the second trimester of pregnancy were associated with an increased chance of developing postpartum depression in women already known to be at risk for the disorder.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported results through month 36 of the completed FAME™ Study.
With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anupam Boparai, MD 4000 Weeks Park Ln Apt 208, Wichita Falls, TX 76308-3201 Ph: () - | Dr Anupam Boparai, MD 1301 3rd St Ste 200, Wichita Falls, TX 76301-2245 Ph: (940) 767-5145 |
News Archive
NovaBay Pharmaceuticals, Inc. today announced that its lead product candidate was safe and efficacious against the highly contagious skin infection impetigo in a Phase 2a proof-of-concept clinical trial. This dose-ranging study showed that the drug cleared impetigo infections, including those in the trial caused by a drug-resistant strain of bacteria called methicillin-resistant Staphylococcus aureus or MRSA. Impetigo afflicts approximately 1 million people, primarily infants and children, in the United States annually.
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
In a small-scale study of women with previously diagnosed mood disorders, Johns Hopkins researchers report that lower levels of the hormone allopregnanolone in the second trimester of pregnancy were associated with an increased chance of developing postpartum depression in women already known to be at risk for the disorder.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported results through month 36 of the completed FAME™ Study.
With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?
› Verified 2 days ago
Dr. Ted Alexander, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4327 Barnett Rd, Wichita Falls, TX 76310 Phone: 940-397-5400 Fax: 940-397-5482 | |
Brandon Christopher Ohman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1620 8th Street, Wichita Falls, TX 76301 Phone: 940-764-5400 Fax: 940-764-5454 | |
Salman S Aleem, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2612 Southwest Pkwy, #129, Wichita Falls, TX 76308 Phone: 940-767-5145 Fax: 940-767-3027 | |
Anas Albrejawi Alhomsi, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1631 11th Street, Unit B, Wichita Falls, TX 76301 Phone: 940-263-3000 Fax: 940-263-3018 | |
Fezan Saleemi, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 3rd St, Suite 200, Wichita Falls, TX 76301 Phone: 940-767-5145 Fax: 940-767-3027 | |
Siby Sam, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 3rd St Ste 200, Wichita Falls, TX 76301 Phone: 940-767-8334 | |
Micheal Allan Moisant, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4412 Kell West Blvd, Wichita Falls, TX 76309 Phone: 940-696-0011 Fax: 940-696-2248 |